555 related articles for article (PubMed ID: 28074314)
1. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A
J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
[TBL] [Abstract][Full Text] [Related]
2. Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.
Gargiulo L; Copsel S; Rivero EM; Galés C; Sénard JM; Lüthy IA; Davio C; Bruzzone A
Oncotarget; 2014 Oct; 5(20):10058-69. PubMed ID: 25375203
[TBL] [Abstract][Full Text] [Related]
3. The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.
Shi M; Liu D; Duan H; Qian L; Wang L; Niu L; Zhang H; Yong Z; Gong Z; Song L; Yu M; Hu M; Xia Q; Shen B; Guo N
Breast Cancer Res Treat; 2011 Jan; 125(2):351-62. PubMed ID: 20237834
[TBL] [Abstract][Full Text] [Related]
4. β2-AR signaling controls trastuzumab resistance-dependent pathway.
Liu D; Yang Z; Wang T; Yang Z; Chen H; Hu Y; Hu C; Guo L; Deng Q; Liu Y; Yu M; Shi M; Du N; Guo N
Oncogene; 2016 Jan; 35(1):47-58. PubMed ID: 25798840
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.
Lam L; Hu X; Aktary Z; Andrews DW; Pasdar M
Breast Cancer Res Treat; 2009 Dec; 118(3):605-21. PubMed ID: 19002577
[TBL] [Abstract][Full Text] [Related]
7. β2-AR activation promotes cleavage and nuclear translocation of Her2 and metastatic potential of cancer cells.
Liu D; Zha L; Liu Y; Zhao X; Xu X; Liu S; Ma W; Zheng J; Shi M
Cancer Sci; 2020 Dec; 111(12):4417-4428. PubMed ID: 33016509
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of exogenous androgen and an androgen receptor antagonist in the peri- and postpubertal murine mammary gland.
Peters AA; Ingman WV; Tilley WD; Butler LM
Endocrinology; 2011 Oct; 152(10):3728-37. PubMed ID: 21846805
[TBL] [Abstract][Full Text] [Related]
9. New insights into fetal mammary gland morphogenesis: differential effects of natural and environmental estrogens.
Speroni L; Voutilainen M; Mikkola ML; Klager SA; Schaeberle CM; Sonnenschein C; Soto AM
Sci Rep; 2017 Jan; 7():40806. PubMed ID: 28102330
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
[TBL] [Abstract][Full Text] [Related]
11. A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer.
Liu D; Deng Q; Sun L; Wang T; Yang Z; Chen H; Guo L; Liu Y; Ma Y; Guo N; Shi M
BMC Cancer; 2015 Nov; 15():832. PubMed ID: 26526356
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.
Xie D; Miller CW; O'Kelly J; Nakachi K; Sakashita A; Said JW; Gornbein J; Koeffler HP
J Biol Chem; 2001 Apr; 276(17):14187-94. PubMed ID: 11297518
[TBL] [Abstract][Full Text] [Related]
13. Estrogen regulation of thrombospondin-1 in human breast cancer cells.
Hyder SM; Liang Y; Wu J
Int J Cancer; 2009 Sep; 125(5):1045-53. PubMed ID: 19391135
[TBL] [Abstract][Full Text] [Related]
14. β-Adrenoceptor Activation in Breast MCF-10A Cells Induces a Pattern of Catecholamine Production Similar to that of Tumorigenic MCF-7 Cells.
Amaro F; Silva D; Reguengo H; Oliveira JC; Quintas C; Vale N; Gonçalves J; Fresco P
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33120955
[TBL] [Abstract][Full Text] [Related]
15. Rhodiola crenulata induces an early estrogenic response and reduces proliferation and tumorsphere formation over time in MCF7 breast cancer cells.
Bassa LM; Jacobs C; Gregory K; Henchey E; Ser-Dolansky J; Schneider SS
Phytomedicine; 2016 Jan; 23(1):87-94. PubMed ID: 26850689
[TBL] [Abstract][Full Text] [Related]
16. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
17. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
Zajchowski DA; Sager R; Webster L
Cancer Res; 1993 Oct; 53(20):5004-11. PubMed ID: 8402691
[TBL] [Abstract][Full Text] [Related]
18. STEAP1 is over-expressed in breast cancer and down-regulated by 17beta-estradiol in MCF-7 cells and in the rat mammary gland.
Maia CJ; Socorro S; Schmitt F; Santos CR
Endocrine; 2008; 34(1-3):108-16. PubMed ID: 18958632
[TBL] [Abstract][Full Text] [Related]
19. Conditional overexpression of liver receptor homolog-1 in female mouse mammary epithelium results in altered mammary morphogenesis via the induction of TGF-β.
Lazarus KA; Brown KA; Young MJ; Zhao Z; Coulson RS; Chand AL; Clyne CD
Endocrinology; 2014 May; 155(5):1606-17. PubMed ID: 24564400
[TBL] [Abstract][Full Text] [Related]
20. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor.
Yeh S; Hu YC; Wang PH; Xie C; Xu Q; Tsai MY; Dong Z; Wang RS; Lee TH; Chang C
J Exp Med; 2003 Dec; 198(12):1899-908. PubMed ID: 14676301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
